Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Bourne

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cells|February 23, 2024
Harnessing Pyroptosis for Cancer ImmunotherapyChristopher M Bourne, Cornelius Y Taabazuing
Developmental Biology|July 23, 2022
Regulators of the secretory pathway have distinct inputs into single-celled branching morphogenesis and seamless tube formation in the Drosophila tracheaChristopher M Bourne, Daniel C Lai, Jodi Schottenfeld-Roames
Mbio|June 5, 2024
Inflammatory caspase substrate specificitiesPatrick M Exconde, Christopher M Bourne, Madhura Kulkarni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejectionLeila Peraro, Christopher M Bourne, Megan M Dacek, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Cancer Discovery|February 6, 2023
Black in Cancer: Two Years of Empowering the Next GenerationChristopher M Bourne, Henry J Henderson, Elshaddai White, et al.
Cancers|August 9, 2020
Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug DeliveryThomas J Gardner, Christopher M Bourne, Megan M Dacek, et al.
Blood Advances|May 13, 2022
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatmentChristopher M Bourne, Sung Soo Mun, Tao Dao, et al.
Blood|January 25, 2023
Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blockerMegan M Dacek, Keifer G Kurtz, Patrick Wallisch, et al.
Science Advances|July 26, 2024
Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to <i>Yersinia</i> blockade of immune signalingRonit Schwartz Wertman, Winslow Yost, Beatrice I Herrmann, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cells|February 23, 2024
Harnessing Pyroptosis for Cancer ImmunotherapyChristopher M Bourne, Cornelius Y Taabazuing
Developmental Biology|July 23, 2022
Regulators of the secretory pathway have distinct inputs into single-celled branching morphogenesis and seamless tube formation in the Drosophila tracheaChristopher M Bourne, Daniel C Lai, Jodi Schottenfeld-Roames
Mbio|June 5, 2024
Inflammatory caspase substrate specificitiesPatrick M Exconde, Christopher M Bourne, Madhura Kulkarni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejectionLeila Peraro, Christopher M Bourne, Megan M Dacek, et al.
Oncoimmunology|June 9, 2021
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapyAngel Charles, Christopher M Bourne, Tanya Korontsvit, et al.
Cancer Discovery|February 6, 2023
Black in Cancer: Two Years of Empowering the Next GenerationChristopher M Bourne, Henry J Henderson, Elshaddai White, et al.
Cancers|August 9, 2020
Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug DeliveryThomas J Gardner, Christopher M Bourne, Megan M Dacek, et al.
Blood Advances|May 13, 2022
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatmentChristopher M Bourne, Sung Soo Mun, Tao Dao, et al.
Blood|January 25, 2023
Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blockerMegan M Dacek, Keifer G Kurtz, Patrick Wallisch, et al.
Science Advances|July 26, 2024
Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to <i>Yersinia</i> blockade of immune signalingRonit Schwartz Wertman, Winslow Yost, Beatrice I Herrmann, et al.
Pageof 2